Title
Successful Treatment of Primary Amoebic Meningoencephalitis Using a Novel Therapeutic Regimen Including Miltefosine and Voriconazole
Date Issued
01 September 2022
Access level
metadata only access
Resource Type
journal article
Publisher(s)
Springer Science and Business Media Deutschland GmbH
Abstract
The genus Naegleria consists of free-living amoebae widely distributed worldwide in soil and freshwater habitats. Primary amoebic meningoencephalitis (PAM) is an uncommon and most likely fatal disease. The incubation period is approximately 7 days. The first symptoms are headache, nasal congestion, fever, vomiting, stiff neck within 3–4 days after the first symptoms, confusion, abnormal behavior, seizures, loss of balance and body control, coma, and death. We describe the case of a child who presented with PAM due to Naegleria sp., fully recovered from the infection without apparent sequels after treatment with a regimen that included miltefosine and voriconazole.
Start page
1421
End page
1424
Volume
67
Issue
3
Language
English
OCDE Knowledge area
Pediatría
Subjects
Scopus EID
2-s2.0-85134536478
PubMed ID
Source
Acta Parasitologica
ISSN of the container
12302821
Sources of information:
Directorio de Producción Científica
Scopus